Drug Shortage Report for KAYEXALATE
| Report ID | 82271 |
| Drug Identification Number | 02026961 |
| Brand name | KAYEXALATE |
| Common or Proper name | Kayexalate |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM POLYSTYRENE SULFONATE |
| Strength(s) | 100% |
| Dosage form(s) | POWDER |
| Route of administration | ORAL RECTAL |
| Packaging size | 1 |
| ATC code | V03AE |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2019-04-26 |
| Actual start date | |
| Estimated end date | 2019-08-30 |
| Actual end date | 2019-05-22 |
| Shortage status | Resolved |
| Updated date | 2019-05-24 |
| Company comments | Production delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2019-05-24 | French | Compare |
| v4 | 2019-05-24 | English | Compare |
| v3 | 2019-04-27 | English | Compare |
| v2 | 2019-04-23 | French | Compare |
| v1 | 2019-04-23 | English | Compare |
Showing 1 to 5 of 5